P-MerP fragment [F5K,A6L,A9R,V13K,V14I]

General Information


DRACP ID  DRACP00849

Peptide Name   P-MerP fragment [F5K,A6L,A9R,V13K,V14I]

Sequence  PMKKLKLALRLAAKIAPVW

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-3 Prostate carcinoma Carcinoma Not active up to 100 µM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma Not active up to 100 µM MTT assay 24h 1
HT-29 Colon adenocarcinoma Carcinoma Not active up to 100 µM MTT assay 24h 1

Hemolytic Activity  Human erythrocytes: Not active up to 100 µM

Normal (non-cancerous) Cytotoxicity  3T3-L1: Not active up to 100 µM; HUVEC: Not active up to 100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00849

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C103H179N27O20S

Absent amino acids  CDEFGHNQSTY

Common amino acids  AKL

Mass  246905

Pl  12

Basic residues  5

Acidic residues  0

Hydrophobic residues  11

Net charge  5

Boman Index  344

Hydrophobicity  46.32

Aliphatic Index  138.95

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  305.56

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30346140

Title  A Computationally Designed Peptide Derived from Escherichia coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies

Doi 10.1021/acsinfecdis.8b00219

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.